Abstract
Gynaecological tumours exemplify many of the molecular paradigms of carcinogenesis. The clinical value of many of the molecular abnormalities present is now being tested and it is likely that the identification of at least some of these will become routine in the near future. This may help to refine diagnosis and guide treatment-for example, therapeutic vaccination for human papillomavirus related disease.
Original language | English |
---|---|
Pages (from-to) | 222-224 |
Number of pages | 3 |
Journal | Molecular Pathology |
Volume | 54 |
Issue number | 4 |
DOIs | |
Publication status | Published - Aug 2001 |